期刊文献+

感染性心内膜炎患者分离株铜绿假单胞菌耐药基因研究 被引量:10

Study of genes responsible for the drug resistance of Pseudomonas aeruginosa in patients with infective endocarditis
原文传递
导出
摘要 目的研究感染性心内膜炎患者分离株铜绿假单胞菌的耐药基因和毒力基因及传播特点,为临床治疗及合理用药打下基础。方法采用琼脂稀释法测定铜绿假单胞菌对12种临床常用抗生素的敏感性,对exoU、exoS、exoT、exoY、toxA和Pyo等6种铜绿假单胞菌毒力基因和铜绿假单胞菌金属酶IMP和VIM基因进行PCR扩增。结果232株铜绿假单胞菌中有75株多重耐药株(MDR),占32.33%。多重耐药株对12种临床常用抗生素耐药率均超过40.00%,其中对环丙沙星和左氧氟沙星耐药率分别为44.00%和49.33%,对亚胺培南和美罗培南耐药率分别为94.67%和93.33%。碳青霉烯类抗生素敏感株对亚胺培南和美罗培南耐药率为0。75株多重耐药株中有32株毒力基因exoU呈阳性,37株毒力基因exoS呈阳性,28株毒力基因exoT呈阳性,11株毒力基因exoY呈阳性,35株毒力基因toxA呈阳性,18株毒力基因Pyo呈阳性。金属β内酰胺酶基因检测,其中21株IMP基因阳性,18株VIM基因阳性。结论心脏内膜炎患者治疗应及时做血培养并进行药敏试验,依据药敏性试验结果进行合理用药。医务人员应注意手部卫生管理,加强器械消毒及病房消毒隔离管理,以利于控制细菌金属β-内酰胺酶基因的传播。 Objective To study genes responsible for the drug resistance of Pseudomonas aeruginosafrom patients with infective endocarditis in order to lay the foundation for clinical treatment of infections and rational use of antibiotics.Methods The sensitivity of P.aeruginosato 12 clinical antibiotics was tested using the agar dilution method.Six genes responsible for the virulence of P.aeruginosa-exoU,exoS,exoT,exoY,toxA and Pyo-and the IMP and VIM genes responsible for metallo-β-lactamase production were amplified using PCR and analyzed using electrophoresis. Results Of232 strains of P.aeruginosa,75 were found to be multidrug-resistant(MDR),accounting for 32.3% of the tested strains.The MDR strains were highly resistant to 12 clinical antibiotics,with a resistance higher than 40%.MDR strains were least resistant to ciprofloxacin(44%)and levofloxacin(49.3%).In contrast,MDR strains were most resistant to imipenem(94.7%)and meropenem(93.3%).Carbapenem-susceptible strains were resistant to imipenem and meropenem at a rate of 0%.Of the 75 strains,32had the exoU gene,37 had the exoS gene,28 had the exoT gene,11 had the exoY gene,35 had the toxA gene,18 had the Pyo gene,21 had the IMP gene,and 18 had the VIM gene. ConclusionTreatment of infective endocarditis should coincide with prompt blood cultures and drug sensitivity testing,with rational antibiotic use based on those results.Hospitals should have medical staff manage their hand hygiene,enhance sterilization of equipment,and disinfect and isolate wards in order to control the metallo-β-lactamase-producing P.aeruginosa.
出处 《中国病原生物学杂志》 CSCD 北大核心 2014年第12期1071-1074,共4页 Journal of Pathogen Biology
关键词 心内膜炎 铜绿假单胞菌 耐药基因 合理用药 Infective endocarditis Pseudomonas aeruginosa drug resistance gene rational use
  • 相关文献

参考文献17

  • 1Li Js, Sexton DJ, Mick N, et al. Proposed modifications to the Duke Criteria for the diagnosis of infective endocarditis [J].Clin Infect Dis, 2000, 30(8): 633-8.
  • 2Guler S, Sokmen A, Mese B, et al. Infective endocarditis develo- ping serious multiple complications[J]. BMJ Case Rep, 2013, 20 (1) - 13.
  • 3Silberbach M. Update: infective endocarditis prophlaxis: reckon ing with the evidence[J]. Pediatr Rev, 2008, 29(5) : 169-70.
  • 4Prenergast BD, TORNOD P. Surgery for infective endocarditis: who and when[J]. Circulation, 2010, 121(9): 1141-52.
  • 5Ostrowski S, Kasielski M, Kordiak J, et al. Elevated resting and agonist-indueed whole blood chemiluminescence in patients with active infective endocarditis[J]. Interact Cardiovasc Thorac Surg, 2009, 8(1): 12-6.
  • 6Kumarasamy KK, Toleman MA, Walsh TR, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study [J]. Lan- cet Infect Dis, 2010, 10(9) : 597-602.
  • 7Biendo M, Canarelli B, Thomas D, et al. Successive emergence of extended-spectrum beta-lactamase-producing and carbapene- mase-producing Enterobacter aerogenes isolates in a university hospital[J]. J Clin Microbiol, 2008, 46(3): 1037-44.
  • 8Shahid M, Malik A, Adil M, et al. Comparison of betaqactamase genes in clinical and food bacterial isolates in India[J]. J Infect Dev Ctries, 2009(3) : 593-8.
  • 9王娟,王前,张秀明,兰海丽,孙各琴,吴秀娟,慕月晶,严海忠.广东中山地区铜绿假单胞菌外膜蛋白OprD2缺失研究[J].中国病原生物学杂志,2014,9(1):71-73. 被引量:5
  • 10Hauser AR, Engel JN. Pseudomonas aeruginosa induces type- Ⅲ-secretion mediated apoptosis of macrophages and epithelial cells[J]. Infect Immune, 1999, 67(10): 5530-7.

二级参考文献39

  • 1许宏涛,张秀珍.医院感染铜绿假单胞菌多重耐药机制的研究[J].中国抗感染化疗杂志,2005,5(3):141-145. 被引量:58
  • 2谢丽丽,熊盛道,刘谨,许淑云,徐永健.铜绿假单胞菌耐亚胺培南相关基因OprD_2研究[J].医药导报,2006,25(2):102-104. 被引量:5
  • 3常东,蒋伟,魏华,王春新,张云杰,糜祖煌.多重耐药铜绿假单胞菌产超广谱β-内酰胺酶基因研究[J].中华医院感染学杂志,2006,16(9):961-964. 被引量:37
  • 4.中国生物制品规程一部 [J].化学工业出版社,2000版.224-225.
  • 5Coburn B,Sekirvo I,Finlay B B.Type Ⅲ secretion systems and disease[J].Clin Microbiol Rev,2007,20(4):535-549.
  • 6Feltman H,Schulert G,Khan S,et al.Prevalence of type Ⅲ secretion genes in clinical and environmental isolates of Pseudomonas aeruginosa[J].Microbiology,2001,147(8):2659-2669.
  • 7Pitout J,Thmoson K S,Hanson N D,et al.Plasmid-mediated resistance to expanded-spectrum cephalosporins among Enterobacter aerogenes strains[J].Antimicrob Agent Chemother,1998,42(3):596-600.
  • 8Ferguson M W,Maxwell J A,Vincent T S,et al.Comparison of the exos gene and protein expression in soil and clinical isolates of Pseudomonas aeruginosa[J].Infect Immun,2001,69(4):2198-2210.
  • 9Escaich S.Antivirulence as a new antibacterial approach for chemotherapy[J].Curr Opin in Chemical Biol,2008,12(4):400-408.
  • 10Hauser A R,Cobb E,Bodi M,et al.Type Ⅱprotein secretion is associated with poor clinical outcomes in patients with ventilator-associated pneumonia caused by Pseudomonas aeruginosa[J].Crit Care Med,2002,30(3):521-528.

共引文献19

同被引文献159

  • 1何汉江,谭立志,刘传爱,姚艳冰,曾焱华.表皮葡萄球菌gyrA基因突变与耐氟喹诺酮类药物的关系[J].实用预防医学,2004,11(6):1116-1119. 被引量:2
  • 2朱学源,刘诗强,陈旭,王微,许浩东,倪语星.表皮葡萄球菌医院感染耐药性的基因型研究[J].中华医院感染学杂志,2007,17(1):1-3. 被引量:8
  • 3中华人民共和国卫生部.医院感染诊断标准[S].北京:中华人民共和国卫生部,2001:7-8.
  • 4宗淑杰,吴明江,秦银河,等.医家金鉴一检验医学(下卷)[M].军事医学科学出版社,597-1346.
  • 5Park Y,Moon Y,Ryoo J,et al.Identification of the minimal region in lipase ABC transporter recognition domain of Pseudo-monas f luorescens for secretion and fluorescence of green fluorescent protein[J].Microb Cell Fact,2012,11(1):60-71.
  • 6Kumarasamy KK,Toleman MA,Walsh TR,et al.Emergence of a new antibiotic resistance mechanism in India,Pakistan,and the UK:a molecular,biological,and epidemiological study[J].Lancet Infect Dis,2010,10(9);597-602.
  • 7Picao RC,Andrade SS,NicoIetti AG,et al.Metallo-β-lactamase detection:comparative evaluation of double-disk synergy versus combined disk tests for IMP-,GIM-,SIM-,SPM-,or VIM -producing isolates[J],J Clin Microbiol,2008,46(6):2028-37.
  • 8Mesaros N,Nordmann P,Plesiat P,et al.Pseudomonas aeruginosa s resistance and therapeutic options at the turn of a new mil-lennium[J].Clin Microbiol Infect,2007(13):560-78.
  • 9Maseda H,Yoneyama H,Nakae T.Assignment of the substrate-selective subunits of the mexef-oprn multidrug efflux pump of Pseudomonas aeruginosa[J].Antimicrob Agents Chemother,2000,44(3):658-64.
  • 10Folkesson A, Jelsbak L, Yang L, et al. Adaptation of Pseudomonas aeruginosa to the cystic fibrosis airway: an evolutionary perspective[J]. Nat Rev Microbiol, 2012, 10(12): 841-851.

引证文献10

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部